The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence

E. L. Nasonov; A. M. Lila

Rheumatology Science and Practice
Naučno-praktičeskaâ revmatologiâ

ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)

User

eng | рус

Rheumatology Science and Practice

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Nasonov E.L., Lila A.M. The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence. Rheumatology Science and Practice. 2019;57(5):564-577. (In Russ.) https://doi.org/10.14412/1995-4484-2019-564-57

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Rheumatology Science and Practice

For citations:

Cookies policy